Top Markets
Coin of the day
Pixium Vision S.A. Pixium Vision S.A.

Pixium Vision S.A.

ALPIX
Clasificación en acciones #40308
Pixium Vision S.A. is a French company at the forefront of bioelectronics and... Pixium Vision S.A. is a French company at the forefront of bioelectronics and brain-machine interface technology, focusing on neuromodulation applications. The company develops the PRIMA System, a sophisticated bionic vision solution aimed at individuals experiencing profound vision loss due to retinal degeneration, specifically the dry atrophic form of Age-related Macular Degeneration (AMD). This system is engineered to combat blindness by effectively replacing the natural function of the eye's photoreceptor cells. It achieves this by electrically stimulating the nerve cells within the inner retina, which then transmit visual information to the brain via the optic nerve. Pixium Vision has established significant collaborative agreements with esteemed institutions such as Stanford University in California, the Institut de la Vision, Moorfields Eye Hospital, the Institute of Ocular Microsurgery, University Hospital, and UPMC. Founded in 2011, the company is headquartered in Paris, France.
Precio por acción
$0.40796816
Última sincronización: 2024-02-28
Capitalización bursátil
$181.55K
Cambio (1 día)
-0.06%
Cambio (1 año)
0.00%
País
FR
Comercio Pixium Vision S.A. (ALPIX)

Categoría

Ganancias de Pixium Vision S.A. (ALPIX)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Pixium Vision S.A., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Pixium Vision S.A. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH